SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Prime Medicine Q3 2026 net loss narrows 23% to $39 million year over year

Prime Medicine Q3 2026 net loss narrows 23% to $39 million year over year Prime Medicine’s third

PRME

Related stories